Sequana Medical NV Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	7.31	3.81	2.58	18.88	9.6	11.02
Cash & Short-Term Investments	7.31	3.81	2.58	18.88	9.6	11.02
Cash Growth	76.10%	47.34%	-86.31%	96.61%	-12.85%	97.19%
Accounts Receivable	-	-	0.04	0.11	0.08	0.02
Other Receivables	1.13	0.86	1.69	1.77	1.37	1.24
Total Trade Receivables	1.13	0.86	1.73	1.89	1.45	1.27
Inventory	2.45	2.05	2.3	2.62	2.14	1.47
Other Current Assets	0.51	0.26	1.06	1.19	0.77	0.62
Total Current Assets	10.58	6.42	6.3	23.09	12.89	13.44
Net Property, Plant & Equipment	1.87	1.77	2.32	2.07	1.27	0.7
Other Intangible Assets	0.26	-	-	-	-	-
Other Long-Term Assets	1.86	1.75	1.49	0.87	0.55	0.07
Total Assets	14.57	9.94	10.1	26.03	14.71	14.21
Accounts Payable	1.12	1.89	2.74	3.23	2.19	2.01
Accrued Expenses	4.18	4.98	6.9	7.17	5.21	2.75
Short-Term Debt	47.01	47.09	10.59	6.05	-	-
Current Portion of Leases	0.25	0.06	0.27	0.31	0.28	0.26
Unearned Revenue	-	-	0.17	0.16	0.17	0.79
Other Current Liabilities	1.68	1.69	2.26	1.81	1.92	1.52
Total Current Liabilities	52.16	53.21	19.47	15.15	7.18	5.97
Long-Term Debt	-	-	8.97	12.19	7.32	7.47
Long-Term Leases	0.73	0.36	0.46	0.61	0.48	0.12
Other Long-Term Liabilities	0.86	0.75	0.67	0.23	0.51	0.54
Total Long-Term Liabilities	1.59	1.11	10.1	13.03	8.31	8.13
Total Liabilities	53.75	54.32	29.57	28.18	15.49	14.1
Common Stock	5.93	4.6	2.93	2.46	1.92	1.64
Additional Paid-in Capital	208.98	201.57	185.64	170.32	142.43	119.33
Accumulated Other Comprehensive Income	0.91	0.85	0.88	0.95	0.22	0.48
Retained Earnings	-254.99	-251.4	-208.92	-175.88	-145.36	-121.33
Shareholders' Equity	-39.17	-44.38	-19.47	-2.15	-0.79	0.11
Total Liabilities & Equity	14.57	9.94	10.1	26.03	14.71	14.21
Total Debt	47.99	47.5	20.29	19.16	8.09	7.86
Net Cash (Debt)	-40.67	-43.69	-17.7	-0.29	1.52	3.16
Net Cash Growth	-	-	-	-	-52.00%	33.66%
Net Cash Per Share	-0.87	-1.19	-0.66	-0.01	0.08	0.21
Book Value	-39.17	-44.38	-19.47	-2.15	-0.79	0.11
Book Value Per Share	-0.84	-1.21	-0.73	-0.09	-0.04	0.01
Tangible Book Value	-39.44	-44.38	-19.47	-2.15	-0.79	0.11
Tangible Book Value Per Share	-0.84	-1.21	-0.73	-0.09	-0.04	0.01